/PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) ("Fusion"), a clinical-stage oncology company focused on developing next-generation targeted alpha.
Fusion Pharmaceuticals (FUSN) Announces 17.6M Share Offering at $3.40/sh, Acquires Phase 2 Program for 225Ac-PSMA I&T streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NOLA Bluedoo is a uniquely-New Orleans-style festival that raises research funds and promotes awareness of prostate cancer. Come enjoy great food, drink, music, costuming, kids' and survivors' tents, a walk/run and MORE, as you help to fight back against this disease that impacts one in seven of our men. All funds raised benefit Dr. Oliver Sartor's Prostate Cancer Research Fund at Tulane Cancer Center. The incomparable Wendell Brunious and his band will be performing a "Tribute to Allen Toussaint" on the NOLA Bluedoo main stage at 4:30 PM
FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions2.